Disulfiram for Alcohol Use Disorder
Disulfiram is NOT recommended for patients with alcoholic liver disease (ALD) due to hepatotoxicity concerns and should be reserved only for highly motivated patients without liver disease who can be closely supervised. 1
What is Disulfiram?
Disulfiram is an FDA-approved alcohol-aversive medication that works by inhibiting aldehyde dehydrogenase (ALDH), causing accumulation of acetaldehyde when alcohol is consumed, resulting in unpleasant physical symptoms (flushing, nausea, vomiting, headache, dyspnea, arrhythmia). 1, 2
Indications
- Aid in management of chronic alcohol use disorder in patients who desire enforced sobriety to allow supportive and psychotherapeutic treatment 2
- Not a cure for alcoholism and is ineffective when used alone without proper motivation and supportive therapy 2
- May be considered for older, socially stable, well-motivated patients who can be supervised for compliance 3
Dosing Regimen
- Standard dose: 250-500 mg/day orally 1, 3
- Lower doses (≤250 mg/day) produce only mild alcohol interactions 4
- Must be initiated only after patient has been abstinent from alcohol for at least 12 hours 2
- Requires continued clinical supervision and monitoring 3
Critical Contraindications
Absolute contraindications: 2
- Recent or concurrent alcohol consumption
- Metronidazole or paraldehyde use
- Severe myocardial disease or coronary occlusion
- Psychoses
- Hypersensitivity to disulfiram or thiuram derivatives
- Alcoholic liver disease (any stage) 1
Major Side Effects and Toxicity
Hepatotoxicity: 1
- Disulfiram undergoes hepatic metabolism and can cause liver damage
- Explicitly excluded from treatment recommendations for ALD patients
Neurologic toxicity: 3
- Can occur at standard dosing (250-500 mg/day)
- Requires monitoring
Cardiac toxicity: 3
- Risk at therapeutic doses
- Contraindicated in severe cardiac disease
Psychiatric effects: 5
- At usual 250 mg/day dosing, does not significantly increase psychiatric complications
- Can be used cautiously in patients with co-occurring psychiatric disorders
Disulfiram-alcohol reaction: 6
- Requires supportive treatment: Trendelenburg position, oxygen, IV fluids
- Pressor agents (norepinephrine) if needed
- Iron salts, ascorbic acid, antihistamines, and phenothiazines are NOT beneficial
Drug Interactions
- Avoid concurrent use with: metronidazole, paraldehyde, any alcohol-containing preparations (cough syrups, tonics) 2
- Psychiatric medications: Generally safe at 250 mg/day dose without significant interactions 5
Clinical Efficacy and Evidence Limitations
Limited evidence for efficacy: 1
- Little evidence supports disulfiram's effect on maintaining abstinence
- Probably effective only in reducing frequency of consumption over short-term (6 months) in compliant patients 3
- No proven effect on long-term alcoholism outcomes 3
Requires supervised compliance: 3
- Most effective when compliance is directly supervised
- Prescription without accompanying education, counseling, and concomitant alcoholism therapy is NOT beneficial 3
Common Clinical Pitfalls
Using in ALD patients: The American Association for the Study of Liver Diseases explicitly states disulfiram is NOT recommended for patients with ALD due to hepatotoxicity 1
Monotherapy approach: Disulfiram alone without psychosocial support is ineffective 2, 3
Inadequate patient education: Patients must clearly understand risks of drinking while taking disulfiram 3
Lack of supervision: Unsupervised compliance significantly reduces effectiveness 3
Preferred Alternatives for ALD Patients
For patients with alcoholic liver disease, use instead: 1
- Acamprosate (666 mg three times daily): No hepatic metabolism, no hepatotoxicity reported
- Baclofen (30-60 mg/day): Only AUD medication tested in RCT showing benefit in cirrhosis patients
- Gabapentin (600-1,800 mg/day): No hepatic metabolism, renally excreted
Avoid in ALD: 1
- Disulfiram (hepatotoxicity)
- Naltrexone (hepatotoxicity concerns, hepatic metabolism)